Hyperuricemia exacerbates chronic cyclosporine nephropathy.

Mazzali, M; Kim, Y G; Suga, S; Gordon, K L; Kang, D H; Jefferson, J A; Hughes, J; Kivlighn, S D; Lan, H Y; Johnson, R J

Mazzali, M; Kim, Y G; Suga, S; Gordon, K L; Kang, D H; Jefferson, J A; Hughes, J; Kivlighn, S D; Lan, H Y; Johnson, R J.

Affiliation

Mazzali M; Division of Nephrology, University of Washington Medical Center, Seattle 98185, USA.

Transplantation ; 71(7): 900-5, 2001 Apr 15.

Article in En | MEDLINE | ID: mdl-11349724

Subject(s)

Cyclosporine; Immunosuppressive Agents; Kidney Diseases/chemically induced; Kidney Diseases/physiopathology; Uric Acid/blood; Animals; Chronic Disease; Collagen/metabolism; Crystallization; Enzyme Inhibitors/pharmacology; Kidney/pathology; Kidney/physiopathology; Kidney Diseases/blood; Macrophages/pathology; Male; Nitric Oxide Synthase/metabolism; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Osteopontin; Oxonic Acid/pharmacology; Rats; Rats, Sprague-Dawley; Reference Values; Sialoglycoproteins/metabolism; Urate Oxidase/antagonists & inhibitors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Uric Acid / Cyclosporine / Immunosuppressive Agents / Kidney Diseases Limits: Animals Language: En Journal: Transplantation Year: 2001 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links